Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oligodendroglioma × Standard of Care × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Pancreatic Neoplasms 6 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Leukemia, Myeloid, Acute 5 Head and Neck Neoplasms 5 Urinary Bladder Neoplasms 4 Neoplasms 4 Multiple Myeloma 4 Lung Neoplasms 4 Leukemia 4 Recurrence 3 Neoplasms, Plasma Cell 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Rectal Neoplasms 2 Radiodermatitis 2 Neoplasms by Site 2 Myelodysplastic Syndromes 2 Melanoma 2 Hematologic Neoplasms 2 Gastrointestinal Neoplasms 2 Carcinoma, Transitional Cell 2 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1

Interventions

Temozolomide 14 Bevacizumab 11 Erlotinib Hydrochloride 5 Radiotherapy 4 Carboplatin 4 Irinotecan 3 Immunoglobulin G 3 Disulfides 3 poly ICLC 2 palbociclib 2 etoposide phosphate 2 Vincristine 2 Sunitinib 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Dasatinib 2 veliparib 1 varlilumab 1 vandetanib 1 trebananib 1 trametinib 1 terameprocol 1 temsirolimus 1 tandutinib 1 selinexor 1 romidepsin 1 picropodophyllin 1 pemigatinib 1 niraparib 1 nintedanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡